Showing results (1051-1060 of 1,061) with videos related to
Sort By:
Pageof 107
Stroke|June 22, 2019
Anticoagulation After Stroke in Patients With Atrial FibrillationRiccardo Altavilla, Valeria Caso, Fabio Bandini, et al.Journal of the American Heart Association|December 21, 2018
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and OutcomesMaurizio Paciaroni, Fabio Bandini, Giancarlo Agnelli, et al.Neurology|December 26, 2025
Emergent Carotid Stenting for Acute Anterior Circulation Ischemic Stroke With Tandem Lesions: The Multicenter CERES-TANDEM StudyMichele Romoli, Carlos A Molina, Elena Zapata-Arriaza, et al.Stroke|February 11, 2017
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score StudyMaurizio Paciaroni, Giancarlo Agnelli, Valeria Caso, et al.European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.Journal of the Neurological Sciences|July 20, 2026
Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.Plos One|June 2, 2022
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysisBhagteshwar Singh, Suzannah Lant, Sofia Cividini, et al.Pageof 107